Immunic
IMUX
0,79 €
Share price
1.83%
Change (1 day)
-35.60%
Change (1 year)
Categories
Immunic (IMUX) - Cash on Hand
Cash on Hand as of December 2024 : €31.32 Million
According to Immunic's latest financial reports the company has €31.32 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunic - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | €42.22 M | -61.08% |
| 2022-12-31 | €0.10 B | 41.45% |
| 2021-12-31 | €76.7 M | -25.98% |
| 2020-12-31 | €0.10 B | 295.24% |
| 2019-12-31 | €26.21 M | 125.1% |
| 2018-12-31 | €11.64 M | -75.44% |
| 2017-12-31 | €47.42 M | -16.85% |
| 2016-12-31 | €57.03 M | -25.24% |
| 2015-12-31 | €76.29 M | -9.25% |
| 2014-12-31 | €84.06 M | 204.02% |
| 2013-12-31 | €27.65 M | 98% |
| 2012-12-31 | €13.96 M | 2158.55% |
| 2011-12-31 | €0.61 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | €0.22 B | 617.62% | 🇺🇸 USA |